Story thread · 2 reports / 2 sources
Unregulated Peptides Have Flooded the Market. Will Regulators Respond?
the-scientist.com · 6h
How the coverage leans
Across 2 sources · syndicated copies counted once
The recent surge of public interest in peptides for health and weight loss belies the drugs’ opaque supply chain and lack of clinical safety and efficacy evidence.
First report: Meet the ‘peppers’ women treating menopause with gray market peptides — which they discuss using secret code words — nypost.com, 2d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.